• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT ANTI-HBS2 (AHBS2) ASSAY; AHBS IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XPT ANTI-HBS2 (AHBS2) ASSAY; AHBS IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem False Positive Result (1227)
Patient Problems No Known Impact Or Consequence To Patient (2692); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/01/2020
Event Type  malfunction  
Manufacturer Narrative
The customer contacted the siemens customer care center (ccc) to report (b)(6) advia centaur xpt (b)(6) results from the same patient.A customer service engineer (cse) was dispatched to the site for system inspection.The patient sample was rerun post service and similar advia centaur xpt (b)(6) results were obtained.Siemens is investigating.Sample rerun results post service: (b)(6).
 
Event Description
(b)(6) advia centaur xpt (b)(6) results were obtained by the customer on the same patient and considered discordant compared to a (b)(6) alternate (b)(6) test method result.The nonreactive alternate (b)(6) test method result was reported to the physician(s) as the correct result.There are no reports that treatment was altered or prescribed or adverse health consequences due to the (b)(6) advia centaur xpt (b)(6) results.
 
Manufacturer Narrative
Mdr 1219913-2020-00182, was filed on (b)(6) 2020, for discordant, false reactive (positive) advia centaur xpt anti-hbs2 (ahbs2) results from the same patient.(b)(6) 2020 - additional information: siemens was informed of patient and lot number information that was not previously provided.B7.The patient has an infectious disease and was tested before surgery.The customer was not able to provide any additional patient information.D4.Lot # 118; expiration date 22-mar-2021.H4.Device manufacture date: 22-mar-2019.The patient sample is not available for further testing.The instructions for use (ifu) under the clinical sensitivity and specificity section lists the 95% confidence interval (ci) for resolved relative specificity as 98.34% - 99.88%, thus false positive results can be expected for this assay.Based on the information provided, and a review of internal data, the one false positive patient sample does not indicate a product problem with advia centaur xpt ahbs2 reagent lot 118.The potential cause for the the false positive result observed by the customer is unknown, however pre-analytical factors, a sample issue, or normal assay performance cannot be ruled out.Incident investigation conclusion is pending customer support feedback.Section h6 result code was updated to reflect the additional information.
 
Manufacturer Narrative
Mdr 1219913-2020-00182 was filed on 23-jul-2020 for false reactive (positive) advia centaur xpt anti-hbs2 (ahbs2) results obtained on the same patient.Mdr 1219913-2020-00182 supplemental report 1 was filed on 21-aug-2020 for additional information.25-aug-2020 additional information: siemens has reviewed the event data and has concluded the incident investigation.A review of internal data indicates advia centaur xpt ahbs2 lot 118 is performing as intended and no product problem was identified.Siemens has received customer support feedback and the customer is operational.In summary, the potential cause for the false positive result observed by the customer is unknown, however pre-analytical factors, a sample issue, or normal assay performance cannot be ruled out.The assay is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XPT ANTI-HBS2 (AHBS2) ASSAY
Type of Device
AHBS IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown, ny
MDR Report Key10317319
MDR Text Key226586652
Report Number1219913-2020-00182
Device Sequence Number1
Product Code LOM
UDI-Device Identifier00630414561790
UDI-Public00630414561790
Combination Product (y/n)N
PMA/PMN Number
P100039
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup,Followup
Report Date 09/16/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/23/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/22/2021
Device Model NumberN/A
Device Catalogue Number10286268
Device Lot Number118
Was Device Available for Evaluation? No
Date Manufacturer Received08/25/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-